Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma
出版年份 2020 全文链接
标题
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma
作者
关键词
-
出版物
ALLERGY
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2020-02-08
DOI
10.1111/all.14221
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Precision medicine and phenotypes, endotypes, genotypes, regiotypes, and theratypes of allergic diseases
- (2019) Ioana Agache et al. JOURNAL OF CLINICAL INVESTIGATION
- Severe asthma: entering an era of new concepts and emerging therapies: Highlights of the 4 th International Severe Asthma Forum, Madrid, 2018
- (2019) S F Seys et al. ALLERGY
- Cost–utility analysis of reslizumab for patients with severe eosinophilic asthma inadequately controlled with high-dose inhaled corticosteroids and long-acting β2-agonists in South Korea
- (2019) Sola Han et al. CURRENT MEDICAL RESEARCH AND OPINION
- Adverse events of benralizumab in moderate to severe eosinophilic asthma
- (2019) Wanshu Liu et al. MEDICINE
- Unmet therapeutic goals and potential treatable traits in a population of patients with severe uncontrolled asthma in Spain. ENEAS study
- (2019) Luis Pérez de Llano et al. RESPIRATORY MEDICINE
- PRS50 BENRALIZUMAB FOR TREATING SEVERE EOSINOPHILIC ASTHMA: NICE SINGLE TECHNOLOGY APPRAISAL
- (2019) I. Tikhonova et al. VALUE IN HEALTH
- Evaluating direct costs and productivity losses of patients with asthma receiving GINA 4/5 therapy in the United States
- (2019) Russell A. Settipane et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Severe asthma phenotypes and endotypes
- (2019) Ioana Agache SEMINARS IN IMMUNOLOGY
- Use of dupilumab on the treatment of moderate-to-severe asthma: a systematic review
- (2019) Cíntia Bassani et al. Revista da Associacao Medica Brasileira
- Rapid and Consistent Improvements in Morning PEF in Patients with Severe Eosinophilic Asthma Treated with Mepolizumab
- (2018) Hector Ortega et al. ADVANCES IN THERAPY
- Mepolizumab in the treatment of severe eosinophilic asthma
- (2018) Ronald A. Strauss et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- A Cost-Effectiveness Analysis of Reslizumab in the Treatment of Poorly Controlled Eosinophilic Asthma
- (2018) Jenny Lam et al. JOURNAL OF ASTHMA
- Asthma
- (2018) Alberto Papi et al. LANCET
- Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma
- (2018) Klaus F. Rabe et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma
- (2018) Mario Castro et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cost-Effectiveness of Biological Asthma Treatments: A Systematic Review and Recommendations for Future Economic Evaluations
- (2018) R. Brett McQueen et al. PHARMACOECONOMICS
- Real-life evaluation of the clinical, functional, and hematological effects of mepolizumab in patients with severe eosinophilic asthma: Results of a single-centre observational study
- (2018) Corrado Pelaia et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Eosinophils Target Therapy for Severe Asthma: Critical Points
- (2018) L. Brussino et al. Biomed Research International
- Omalizumab lowers asthma exacerbations, oral corticosteroid intake and blood eosinophils: Results of a 5-YEAR single-centre observational study
- (2018) Corrado Pelaia et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- dIvergEnt: How IgE Axis Contributes to the Continuum of Allergic Asthma and Anti-IgE Therapies
- (2017) Óscar Palomares et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Meta-analysis of asthma-related hospitalization in mepolizumab studies of severe eosinophilic asthma
- (2017) Steven W. Yancey et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Efficacy and safety of benralizumab for eosinophilic asthma: A systematic review and meta-analysis of randomized controlled trials
- (2017) Bao-ping Tian et al. JOURNAL OF ASTHMA
- Oral Glucocorticoid–Sparing Effect of Benralizumab in Severe Asthma
- (2017) Parameswaran Nair et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial
- (2017) Geoffrey L Chupp et al. Lancet Respiratory Medicine
- Methods for including information from multi-arm trials in pairwise meta-analysis
- (2017) Gerta Rücker et al. Research Synthesis Methods
- Serum IL-5 and IL-13 consistently serve as the best predictors for the blood eosinophilia phenotype in adult asthmatics
- (2016) I. Agache et al. ALLERGY
- Characterization of asthma endotypes: implications for therapy
- (2016) Jeffrey R. Stokes et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Measuring Eosinophils to Make Treatment Decisions in Asthma
- (2016) Parameswaran Nair et al. CHEST
- Phase 3 Study of Reslizumab in Patients With Poorly Controlled Asthma
- (2016) Jonathan Corren et al. CHEST
- Reslizumab for Inadequately Controlled Asthma With Elevated Blood Eosinophil Levels
- (2016) Leif Bjermer et al. CHEST
- The efficacy and safety of reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: A systematic review and meta-analysis
- (2016) Jinfeng Li et al. JOURNAL OF ASTHMA
- Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial
- (2016) Eugene R Bleecker et al. LANCET
- Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial
- (2016) Sally Wenzel et al. LANCET
- Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial
- (2016) J Mark FitzGerald et al. LANCET
- Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials
- (2015) Mario Castro et al. Lancet Respiratory Medicine
- Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma
- (2014) Elisabeth H. Bel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
- (2014) Hector G. Ortega et al. NEW ENGLAND JOURNAL OF MEDICINE
- External validation of blood eosinophils, FENOand serum periostin as surrogates for sputum eosinophils in asthma
- (2014) A H Wagener et al. THORAX
- Exploring the Effects of Omalizumab in Allergic Asthma
- (2013) Nicola A. Hanania et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
- (2013) K. F. Chung et al. EUROPEAN RESPIRATORY JOURNAL
- Biomarker surrogates do not accurately predict sputum eosinophil and neutrophil percentages in asthmatic subjects
- (2013) Annette T. Hastie et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- High eosinophil count: A potential biomarker for assessing successful omalizumab treatment effects
- (2013) William Busse et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Reassessment of Omalizumab-Dosing Strategies and Pharmacodynamics in Inner-City Children and Adolescents
- (2013) Christine A. Sorkness et al. Journal of Allergy and Clinical Immunology-In Practice
- Asthma Symptom Utility Index: Reliability, validity, responsiveness, and the minimal important difference in adult asthmatic patients
- (2012) Christian Bime et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Reslizumab for Poorly Controlled, Eosinophilic Asthma
- (2011) Mario Castro et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- An Official ATS Clinical Practice Guideline: Interpretation of Exhaled Nitric Oxide Levels (FeNO) for Clinical Applications
- (2011) Raed A. Dweik et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- GRADE guidelines: 9. Rating up the quality of evidence
- (2011) Gordon H. Guyatt et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Economic Evaluations in the EURONHEED
- (2009) Florencia Hutter et al. PHARMACOECONOMICS
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
- (2008) Gordon H Guyatt et al. BMJ-British Medical Journal
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started